Home » Topics » Regulatory

Regulatory
RSS

Ganfort approved for glaucoma in E.U.

May 29, 2006

Remicade approved as first biologic treatment for active pediatric Crohn's disease

May 22, 2006

FDA approval for smoking cessation therapy Chantix

May 12, 2006

New higher dose formulations of Diovan HCT approved

May 5, 2006

Dacogen approved for myelodysplastic syndromes

May 4, 2006

European approval for Preotact

April 27, 2006

Feron approved in Japan for compensatory cirrhosis C

April 21, 2006

Pramipexole approved in Europe for restless legs syndrome

April 10, 2006

Myozyme approved for Pompe disease in Europe

April 4, 2006

Relenza approved for prophylactic use, GSK advances pandemic flu vaccines

April 3, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...